Abnormal Tr1 differentiation in multiple sclerosis

Journal of Neuroimmunology

Volumn 191, Issue 1-2, 2007, Pages 70-78

  Astier, Anne L ^a   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD46; IL 10; Multiple sclerosis; Tr1 regulatory T cells

Indexed keywords

INTERLEUKIN 10; MEMBRANE COFACTOR PROTEIN;

BLOOD BRAIN BARRIER; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE RESPONSE; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD46; CELL DIFFERENTIATION; HERPESVIRUS 6, HUMAN; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; PROTEIN ISOFORMS; T-LYMPHOCYTES, REGULATORY;

EID: 35848964590     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.018     Document Type: Review

References (109)

1. Adorini L. Immunotherapeutic approaches in multiple sclerosis. J. Neurol. Sci. 223 (2004) 13-24
2. Alvarez-Lafuente R., Garcia-Montojo M., De Las Heras V., Bartolome M., and Arroyo R. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. J. Clin. Virol. 37 Suppl 1 (2006) S24-S26
3. Anderson A.C., Reddy J., Nazareno R., Sobel R.A., Nicholson L.B., and Kuchroo V.K. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173 (2004) 828-834
4. Antel J., Bania M., Noronha A., and Neely S. Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis. J. Immunol. 137 (1986) 3436-3439
5. Asseman C., Mauze S., Leach M.W., Coffman R.L., and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190 (1999) 995-1004
6. Astier A., Trescol-Biemont M.C., Azocar O., Lamouille B., and Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164 (2000) 6091-6095
7. Astier A.L., Meiffren G., Freeman S., and Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116 (2006) 3252-3257
8. Bacchetta R., Bigler M., Touraine J.L., Parkman R., Tovo P.A., Abrams J., de Waal Malefyt R., de Vries J.E., and Roncarolo M.G. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179 (1994) 493-502
9. Bach J.F. Non-Th2 regulatory T-cell control of Th1 autoimmunity. Scand. J. Immunol. 54 (2001) 21-29
10. Baecher-Allan C., Brown J.A., Freeman G.J., and Hafler D.A. CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. 167 (2001) 1245-1253
11. Baecher-Allan, C., Brown, J.A., Freeman, G.J., Hafler, D.A., 2003. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found Symp 252, 67-88; discussion 88-91, 106-114.
12. Balandina A., Lecart S., Dartevelle P., Saoudi A., and Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105 (2005) 735-741
13. Balashov K.E., Comabella M., Ohashi T., Khoury S.J., and Weiner H.L. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS. Neurology 55 (2000) 192-198
14. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., and O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195 (2002) 603-616
15. Beebe A.M., Cua D.J., and de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 13 (2002) 403-412
16. Berg D.J., Leach M.W., Kuhn R., Rajewsky K., Muller W., Davidson N.J., and Rennick D. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182 (1995) 99-108
17. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., and Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161 (1998) 3299-3306
18. Bluestone J.A., and Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity?. Curr. Opin. Immunol. 17 (2005) 638-642
19. Bruck W. Clinical implications of neuropathological findings in multiple sclerosis. J. Neurol. 252 Suppl 3 (2005) iii10-iii14
20. Burkhart C., Liu G.Y., Anderton S.M., Metzler B., and Wraith D.C. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. 11 (1999) 1625-1634
21. Cantorna M.T., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 7861-7864
22. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78 (2004) 4385-4388
23. Chabot S., and Yong V.W. Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS. Neurology 55 (2000) 1497-1505
24. Challoner P.B., Smith K.T., Parker J.D., MacLeod D.L., Coulter S.N., Rose T.M., Schultz E.R., Bennett J.L., Garber R.L., Chang M., et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7440-7444
25. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237-1240
26. Christen U., and von Herrath M.G. Initiation of autoimmunity. Curr. Opin. Immunol. 16 (2004) 759-767
27. Clerici M., Saresella M., Trabattoni D., Speciale L., Fossati S., Ruzzante S., Cavaretta R., Filippi M., Caputo D., and Ferrante P. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J. Neuroimmunol. 121 (2001) 88-101
28. Correale J., Gilmore W., McMillan M., Li S., McCarthy K., Le T., and Weiner L.P. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 154 (1995) 2959-2968
29. Crisi G.M., Santambrogio L., Hochwald G.M., Smith S.R., Carlino J.A., and Thorbecke G.J. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur. J. Immunol. 25 (1995) 3035-3040
30. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., and Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189 (1999) 1005-1010
31. Dhiman N., Jacobson R.M., and Poland G.A. Measles virus receptors: SLAM and CD46. Rev. Med. Virol. 14 (2004) 217-229
32. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193 (2001) 1303-1310
33. Feldmann M., and Steinman L. Design of effective immunotherapy for human autoimmunity. Nature 435 (2005) 612-619
34. Fernandez-Centeno E., de Ojeda G., Rojo J.M., and Portoles P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J. Immunol. 164 (2000) 4533-4542
35. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
36. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1151
37. Gray C.P., Arosio P., and Hersey P. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. Clin. Cancer. Res. 9 (2003) 2551-2559
38. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., and Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104 (2004) 2840-2848
39. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., and Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
40. Haas J., Hug A., Viehover A., Fritzsching B., Falk C.S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P.H., Suri-Payer E., and Wildemann B. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 (2005) 3343-3352
41. Hafler D.A., and De Jager P.L. Applying a new generation of genetic maps to understand human inflammatory disease. Nat. Rev. Immunol. 5 (2005) 83-91
42. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol. Rev. 204 (2005) 208-231
43. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R., and Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104 (2004) 895-903
44. Hohlfeld R., and Wekerle H. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc. Natl. Acad. Sci. U. S. A. 101 Suppl. 2 (2004) 14599-14606
45. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
46. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., and Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81 (2005) 45-52
47. Ito T., Wang Y.H., Duramad O., Hanabuchi S., Perng O.A., Gilliet M., Qin F.X., and Liu Y.J. OX40 ligand shuts down IL-10-producing regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13138-13143
48. Jimenez-Perianez A., Ojeda G., Criado G., Sanchez A., Pini E., Madrenas J., Rojo J.M., and Portoles P. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts. J. Leukoc. Biol. 78 (2005) 1386-1396
49. Johansson L., Rytkonen A., Bergman P., Albiger B., Kallstrom H., Hokfelt T., Agerberth B., Cattaneo R., and Jonsson A.B. CD46 in meningococcal disease. Science 301 (2003) 373-375
50. Johnstone R.W., Russell S.M., Loveland B.E., and McKenzie I.F. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol. Immunol. 30 (1993) 1231-1241
51. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
52. Kallstrom H., Blackmer Gill D., Albiger B., Liszewski M.K., Atkinson J.P., and Jonsson A.B. Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell. Microbiol. 3 (2001) 133-143
53. Kemper C., and Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 7 (2007) 9-18
54. Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., and Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 (2003) 388-392
55. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
56. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002) 4712-4716
57. Kretschmer K., Apostolou I., Jaeckel E., Khazaie K., and von Boehmer H. Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol. Rev. 212 (2006) 163-169
58. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
59. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., and Roncarolo M.G. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166 (2001) 5530-5539
60. Liu Y., Hao W., Letiembre M., Walter S., Kulanga M., Neumann H., and Fassbender K. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 26 (2006) 12904-12913
61. Mackenzie D.A., Schartner J., Lin J., Timmel A., Jennens-Clough M., Fathman C.G., and Seroogy C.M. GRAIL is upregulated in CD4+CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J. Biol. Chem. (2007)
62. Maloy K.J., and Powrie F. Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat. Immunol. 6 (2005) 1071-1072
63. Marie J.C., Astier A.L., Rivailler P., Rabourdin-Combe C., Wild T.F., and Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 3 (2002) 659-666
64. McNeill A., Spittle E., and Backstrom B.T. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand. J. Immunol. 65 (2007) 63-69
65. McQualter J.L., and Bernard C.C. Multiple sclerosis: a battle between destruction and repair. J. Neurochem. 100 (2007) 295-306
66. Meiffren G., Flacher M., Azocar O., Rabourdin-Combe C., and Faure M. Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathway. J. Immunol. 177 (2006) 4957-4961
67. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
68. Morgan B.P., Marchbank K.J., Longhi M.P., Harris C.L., and Gallimore A.M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 97 (2005) 171-179
69. Navikas V., Link J., Palasik W., Soderstrom M., Fredrikson S., Olsson T., and Link H. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand. J. Immunol. 41 (1995) 171-178
70. Nishibori T., Tanabe Y., Su L., and David M. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199 (2004) 25-34
71. Noma K., Yamaguchi Y., Okita R., Matsuura K., and Toge T. The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta. Anticancer. Res. 25 (2005) 643-649
72. Oliaro J., Pasam A., Waterhouse N.J., Browne K.A., Ludford-Menting M.J., Trapani J.A., and Russell S.M. Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18685-18690
73. Ono M., Shimizu J., Miyachi Y., and Sakaguchi S. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells. J. Immunol. 176 (2006) 4748-4756
74. Ozenci V., Kouwenhoven M., Huang Y.M., Xiao B., Kivisakk P., Fredrikson S., and Link H. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Scand. J. Immunol. 49 (1999) 554-561
75. Paust S., and Cantor H. Regulatory T cells and autoimmune disease. Immunol. Rev. 204 (2005) 195-207
76. Petereit H.F., Pukrop R., Fazekas F., Bamborschke S.U., Ropele S., Kolmel H.W., Merkelbach S., Japp G., Jongen P.J., Hartung H.P., and Hommes O.R. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. J. Neurol. Sci. 206 (2003) 209-214
77. Price J.D., Schaumburg J., Sandin C., Atkinson J.P., Lindahl G., and Kemper C. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 175 (2005) 677-684
78. Putheti P., Pettersson A., Soderstrom M., Link H., and Huang Y.M. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 24 (2004) 155-161
79. Riley-Vargas R.C., Gill D.B., Kemper C., Liszewski M.K., and Atkinson J.P. CD46: expanding beyond complement regulation. Trends. Immunol. 25 (2004) 496-503
80. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., Pratap S., Toms C., Fox B.C., Cerundolo V., Powrie F., and Banham A.H. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35 (2005) 1681-1691
81. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., and Levings M.K. Type 1 T regulatory cells. Immunol. Rev. 182 (2001) 68-79
82. Rott O., Fleischer B., and Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24 (1994) 1434-1440
83. Russell S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 64 (2004) 111-118
84. Russell S.M., Loveland B.E., Johnstone R.W., Thorley B.R., and McKenzie I.F. Functional characterisation of alternatively spliced CD46 cytoplasmic tails. Transplant. Proc. 24 (1992) 2329-2330
85. Sakaguchi S., Fukuma K., Kuribayashi K., and Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161 (1985) 72-87
86. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
87. Samoilova E.B., Horton J.L., and Chen Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell. Immunol. 188 (1998) 118-124
88. Sanchez A., Feito M.J., and Rojo J.M. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 34 (2004) 2439-2448
89. Santoro F., Kennedy P.E., Locatelli G., Malnati M.S., Berger E.A., and Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 99 (1999) 817-827
90. Seya T., Hirano A., Matsumoto M., Nomura M., and Ueda S. Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions. Int. J. Biochem. Cell. Biol. 31 (1999) 1255-1260
91. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2 (2002) 116-126
92. Shusta E.V., Zhu C., Boado R.J., and Pardridge W.M. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J. Neuropathol. Exp. Neurol. 61 (2002) 597-604
93. Soldan S.S., Alvarez Retuerto A.I., Sicotte N.L., and Voskuhl R.R. Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis. J. Neuroimmunol. 146 (2004) 209-215
94. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., Brennan M.B., Maloni H.W., McFarland H.F., Lin H.C., Patnaik M., and Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3 (1997) 1394-1397
95. Spach K.M., Nashold F.E., Dittel B.N., and Hayes C.E. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 6030-6037
96. Stephens L.A., Mottet C., Mason D., and Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31 (2001) 1247-1254
97. Taams L.S., Smith J., Rustin M.H., Salmon M., Poulter L.W., and Akbar A.N. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31 (2001) 1122-1131
98. Taylor P.A., Noelle R.J., and Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193 (2001) 1311-1318
99. Vaknin-Dembinsky A., Balashov K., and Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 176 (2006) 7768-7774
100. van Boxel-Dezaire A.H., Hoff S.C., van Oosten B.W., Verweij C.L., Drager A.M., Ader H.J., van Houwelingen J.C., Barkhof F., Polman C.H., and Nagelkerken L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45 (1999) 695-703
101. Vandenbark A.A., Finn T., Barnes D., Culbertson N., Chou Y.K., Hicks K., Bakke A., Mass M., Whitham R., Offner H., and Bourdette D. Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene. J. Neurosci. Res. 66 (2001) 171-176
102. Venken K., Hellings N., Hensen K., Rummens J.L., Medaer R., D'Hooghe M.B., Dubois B., Raus J., and Stinissen P. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 83 (2006) 1432-1446
103. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., Barthlott T., Stockinger B., Wraith D.C., and O'Garra A. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172 (2004) 5986-5993
104. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
105. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., and Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112 (2003) 1437-1443
106. Wraith D.C., Nicolson K.S., and Whitley N.T. Regulatory CD4+ T cells and the control of autoimmune disease. Curr. Opin. Immunol. 16 (2004) 695-701
107. Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., Richards D.F., Adikibi T., Pridgeon C., Dallman M., Loke T.K., Robinson D.S., Barrat F.J., O'Garra A., Lavender P., Lee T.H., Corrigan C., and Hawrylowicz C.M. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 116 (2006) 146-155
108. Zaffran Y., Destaing O., Roux A., Ory S., Nheu T., Jurdic P., Rabourdin-Combe C., and Astier A.L. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167 (2001) 6780-6785
109. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 249-256